BMPR1A promotes ID2–ZEB1 interaction to suppress excessive endothelial to mesenchymal transition
Cardiovascular Research · 02.05.2023 · 119 (3) · 813-825
DOI: 10.1093/cvr/cvac159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 27.09.2022. Verfasst von Heon-Woo Lee und 17 weiteren Autor:innen. Beteiligte Einrichtung: Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Hav…. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein Receptors, Type I, Hypertension, Pulmonary, Pulmonary Arterial Hypertension, Inhibitor of Differentiation Protein 2. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, National Institute of Health.
Abstract (Originalsprache)
Aims
Components of bone morphogenetic protein (BMP) signalling have been implicated in both pathogenesis of pulmonary arterial hypertension (PAH) and endothelial-mesenchymal transition (EndoMT). In particular, the importance of BMP type 2 receptor in these processes has been extensively analysed. However, the contribution of BMP type 1 receptors (BMPR1s) to the onset of PAH and EndoMT remains poorly understood. BMPR1A, one of BMPR1s, was recently implicated in the pathogenesis of PAH, and was found to be down-regulated in the lungs of PAH patients, neither the downstream mechanism nor its contribution to EndoMT has been described. Therefore, we aim to delineate the role of endothelial BMPR1A in modulating EndoMT and pathogenesis of PAH. Methods and results We find that BMPR1A knockdown in endothelial cells (ECs) induces hallmarks of EndoMT, and deletion of endothelial Bmpr1a in adult mice (Bmpr1aiECKO) leads to development of PAH-like symptoms due to excessive EndoMT. By lineage tracing, we show that endothelial-derived smooth muscle cells are increased in endothelial Bmpr1a-deleted mice. Mechanistically, we identify ZEB1 as a primary target for BMPR1A in this setting; upon BMPR1A activation, ID2 physically interacts and sequesters ZEB1 to attenuate transcription of Tgfbr2, which in turn lowers the responses of ECs towards transforming growth factor beta (TGFβ) stimulation and prevents excessive EndoMT. In Bmpr1aiECKO mice, administering endothelial targeting lipid nanoparticles containing siRNA against Tgfbr2 effectively ameliorate PAH, reiterating the importance of BMPR1A-ID2/ZEB1-TGFBR2 axis in modulating progression of EndoMT and pathogenesis of PAH.
Conclusions
We demonstrate that BMPR1A is key to maintain endothelial identity and to prevent excessive EndoMT. We identify BMPR1A-induced interaction between ID2 and ZEB1 is the key regulatory step for onset of EndoMT and pathogenesis of PAH. Our findings indicate that BMPR1A-ID2/ZEB1-TGFBR2 signalling axis could serve as a potential novel therapeutic target for PAH and other EndoMT-related vascular disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06511, USA.
- Division of Nephrology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- School of Life Sciences and Cell Logistics Research Center, Gwangju Institute of Science and Technology (GIST), Gwangju, Korea.
- David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- Division of Pulmonary and Critical Care, Brigham and Women's Hospital, Boston, MA 02127, USA.
- Division of Biological Sciences, Sookmyung Women's University, Seoul 04310, Korea.
ORCID-Profile: Heon-Woo Lee
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
- National Institute of Health
- American Heart Association
- National Research Foundation of Korea
Zitieren
APA
Lee, H. W., Adachi, T., Pak, B., Park, S., Hu, X., Choi, W., Kowalski, P. S., Chang, C. H., Clapham, K. R., Lee, A., Papangeli, I., Kim, J., Han, O., Park, J., Anderson, D. G., Simons, M., Jin, S. W., & Chun, H. J. (2023). BMPR1A promotes ID2–ZEB1 interaction to suppress excessive endothelial to mesenchymal transition. Cardiovascular Research, 119(3), 813-825. https://doi.org/10.1093/cvr/cvac159
Vancouver
Lee HW, Adachi T, Pak B, Park S, Hu X, Choi W, et al. BMPR1A promotes ID2–ZEB1 interaction to suppress excessive endothelial to mesenchymal transition. Cardiovascular Research. 2023;119(3):813-825. doi:10.1093/cvr/cvac159
BibTeX
@article{Lee2023,
author = {Lee, Heon-Woo and Adachi, Takaomi and Pak, Boryeong and Park, Saejeong and Hu, Xiaoyue and Choi, Woosoung and Kowalski, Piotr S and Chang, C Hong and Clapham, Katharine R and Lee, Aram and Papangeli, Irinna and Kim, Jongmin and Han, Orjin and Park, Jihwan and Anderson, Daniel G and Simons, Michael and Jin, Suk-Won and Chun, Hyung J},
title = {BMPR1A promotes ID2–ZEB1 interaction to suppress excessive endothelial to mesenchymal transition},
journal = {Cardiovascular Research},
year = {2023},
volume = {119},
number = {3},
pages = {813--825},
doi = {10.1093/cvr/cvac159}
}
EUVIMED